Given that CD79b plays a crucial role in mediating signaling through the BCR upon antigen binding, we can only speculate on the functional consequences of the low or absent expression of CD79b and its potential impact on the alteration of the signaling pathway in lymphoma cells. This evidence concerns the gene BCR and lymphoma.